Latest Breaking News On - Keros therapeutics - Page 1 : vimarsana.com

Keros Therapeutics Appoints Jean-Jacques Bienaimé To Its Board Of Directors

Keros Therapeutics Appoints Jean-Jacques Bienaimé To Its Board Of Directors
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

France generalJasbir seehraJean jacques bienaimePoulenc rorer pharmaceuticalsGenentech incBiomarin pharmaceutical incGenencor incKeros therapeutics incCompany nasdaqIncyte corporationWharton schoolUniversity of pennsylvaniaBusiness developmentImmunome incSangstat medical corporationChief executive officer jasbir seehra

Keros Therapeutics to Present at the 29th Annual Congress of the European Hematology Association

Keros Therapeutics to Present at the 29th Annual Congress of the European Hematology Association
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Justin frantzKeros therapeutics incEuropean hematology associationExchange commissionCompany quarterly report on formAnnual congressEuropean hematologyKeros therapeuticsPrivate securities litigation reform actQuarterly report

Keros Therapeutics, Inc (NASDAQ:KROS) Receives $86 00 Consensus Target Price from Brokerages

Keros Therapeutics, Inc (NASDAQ:KROS) Receives $86 00 Consensus Target Price from Brokerages
etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.

United statesPiper sandlerWilliam blairVanguard group incBarclays plcKeros therapeutics incChina universal asset management coYork mellon corpKeros therapeuticsGet free reportUniversal asset managementNew york mellon corpGet freeKeros therapeutics daily

Keros Therapeutics (NASDAQ:KROS) Stock Rating Reaffirmed by HC Wainwright

Keros Therapeutics (NASDAQ:KROS) Stock Rating Reaffirmed by HC Wainwright
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

United statesWilliam blairPiper sandlerKeros therapeutics incSwiss national bankPrincipal financial group incProshare advisorsMirae asset global investments coCapital partnersKeros therapeuticsGet free reportAsset global investmentsFinancial groupShare advisorsNational bankKeros therapeutics daily

KROS Stock Earnings: Keros Therapeutics Beats EPS for Q1 2024

KROS Stock Earnings: Keros Therapeutics Beats EPS for Q1 2024
biztoc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biztoc.com Daily Mail and Mail on Sunday newspapers.

Keros therapeuticsPlace earnings